au.\*:("BYRD, John C")
Results 1 to 25 of 158
Selection :
CS1-Directed Monoclonal Antibody Therapy for Multiple MyelomaBENSON, Don M; BYRD, John C.Journal of clinical oncology. 2012, Vol 30, Num 16, pp 2013-2015, issn 0732-183X, 3 p.Article
Immunostimulatory CpG oligodeoxynucleotides and antibody therapy of cancerJAHRSDÖDER, Bernd; WEINER, George J.Seminars in oncology. 2003, Vol 30, Num 4, pp 476-482, issn 0093-7754, 7 p.Article
Chronic lymphocytic leukemiaBYRD, John C; GREVER, Michael R.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, 121 p.Serial Issue
Treatment of low-grade B-cell lymphoma with the monoclonal antibody rituximabDILLMAN, Robert O.Seminars in oncology. 2003, Vol 30, Num 4, pp 434-447, issn 0093-7754, 14 p.Article
Rituximab in Chronic Lymphocytic LeukemiaJAGLOWSKI, Samantha M; BYRD, John C.Seminars in hematology. 2010, Vol 47, Num 2, pp 156-169, issn 0037-1963, 14 p.Article
Pentostatin (nipent) and high-dose cyclophosphamide for the treatment of refractory autoimmune disordersGOODMAN, M.Seminars in oncology. 2000, Vol 27, Num 2, pp 67-71, issn 0093-7754, SUP5Conference Paper
Future development of pentostatin (Nipent): opportunities for using a highly effective, safe agent for hematologic and autoimmune diseasesBYRD, John C; GREVER, Michael R.Seminars in oncology. 2000, Vol 27, Num 2, issn 0093-7754, 110 p., SUP5Conference Proceedings
The B-cell receptor signaling pathway as a therapeutic target in CLLWOYACH, Jennifer A; JOHNSON, Amy J; BYRD, John C et al.Blood. 2012, Vol 120, Num 6, pp 1175-1184, issn 0006-4971, 10 p.Article
Mechanism of action and resistance to monoclonal antibody therapyVILLAMOR, Neus; MONTSERRAT, Emili; COLOMER, Dolors et al.Seminars in oncology. 2003, Vol 30, Num 4, pp 424-433, issn 0093-7754, 10 p.Article
Phase II trials of pentostatin (nipent) in hairy cell leukemiaKRAUT, E. H.Seminars in oncology. 2000, Vol 27, Num 2, pp 27-31, issn 0093-7754, SUP5Conference Paper
Antibodies for the treatment of diffuse large cell lymphomaBLUM, Kristie A; BARTLETT, Nancy L.Seminars in oncology. 2003, Vol 30, Num 4, pp 448-456, issn 0093-7754, 9 p.Article
HLA class II antibodies in the treatment of hematologic malignanciesDECHANT, Michael; BRUENKE, Joerg; VALERIUS, Thomas et al.Seminars in oncology. 2003, Vol 30, Num 4, pp 465-475, issn 0093-7754, 11 p.Article
Second malignancies in B-cell chronic lymphocytic leukaemia: possible association with human papilloma virusFLYNN, Joseph M; ANDRITSOS, Leslie; LUCAS, David et al.British journal of haematology. 2010, Vol 149, Num 3, pp 388-390, issn 0007-1048, 3 p.Article
Autoimmune complications of chronic lymphocytic leukemiaHAMBLIN, Terry J.Seminars in oncology. 2006, Vol 33, Num 2, pp 230-239, issn 0093-7754, 10 p.Article
Concurrent pernicious anemia and myelodysplastic syndromeDRABICK, Joseph J; DAVIS, Brad J; BYRD, John C et al.Annals of hematology (Print). 2001, Vol 80, Num 4, pp 243-245, issn 0939-5555Article
Activity of pentostatin (nipent) in cutaneous T-cell lymphoma : Single-agent and combination studiesFOSS, F. M.Seminars in oncology. 2000, Vol 27, Num 2, pp 58-63, issn 0093-7754, SUP5Conference Paper
Novel therapeutic approaches for hematologic malignancies in the 21st centuryBYRD, John C; CALIGIURI, Michael A; GREVER, Michael R et al.Seminars in oncology. 2000, Vol 27, Num 5, issn 0093-7754, 125 p.Serial Issue
New developments in antibody therapy for acute myeloid leukemiaTOMBLYN, Marcie R; TALLMAN, Martin S.Seminars in oncology. 2003, Vol 30, Num 4, pp 502-508, issn 0093-7754, 7 p.Article
Monoclonal antibodies for the prevention and treatment of graft-versus-host diseaseBRUNER, Rebecca J; FARAG, Sherif S.Seminars in oncology. 2003, Vol 30, Num 4, pp 509-519, issn 0093-7754, 11 p.Article
Incorporating monoclonal antibodies in blood and marrow transplantationMALEK, Sami N; FLINN, Ian W.Seminars in oncology. 2003, Vol 30, Num 4, pp 520-530, issn 0093-7754, 11 p.Article
An old drug for a new disease : Pentostatin (nipent) in acute graft-versus-host diseaseMARGOLIS, J; VOGELSANG, G.Seminars in oncology. 2000, Vol 27, Num 2, pp 72-77, issn 0093-7754, SUP5Conference Paper
Risk stratification in chronic lymphocytic leukemiaSEILER, Till; DÖHNER, Hartmut; STILGENBAUER, Stephan et al.Seminars in oncology. 2006, Vol 33, Num 2, pp 186-194, issn 0093-7754, 9 p.Article
Clinical utility of flow cytometry in the chronic lymphoid leukemiasDIGIUSEPPE, J. A; BOROWITZ, M.Seminars in oncology. 1998, Vol 25, Num 1, pp 6-10, issn 0093-7754Article
Cytogenetics in chronic lymphocytic leukemiaJULIUSSON, G; MERUP, M.Seminars in oncology. 1998, Vol 25, Num 1, pp 19-26, issn 0093-7754Article
Familial chronic lymphocytic leukemiaSELLICK, Gabrielle S; CATOVSKY, Daniel; HOULSTON, Richard S et al.Seminars in oncology. 2006, Vol 33, Num 2, pp 195-201, issn 0093-7754, 7 p.Article